Medanta Global Health Limited (NSE: Medanta, BSE: 543654) has launched its sixth hospital, a 550-bed super-specialty facility in Noida, integrating cutting-edge medical technologies to enhance patient care. Operational since September 2025 with 226 beds, 81 ICU beds, and five operating theatres, the hospital has onboarded 151 doctors across key specialties. Advanced diagnostic and treatment equipment reflects Medanta’s focus on innovation-driven healthcare delivery in Delhi/NCR.
For Q2 FY2026, Medanta reported consolidated total income of INR 11,189 million, up 14.8% year-on-year, with net profit rising 21.1% to INR 1,584 million. EBITDA excluding Noida increased 13.7% to INR 2,804 million. Mature hospitals generated INR 7,200 million in revenue, while developing hospitals excluding Noida grew 28.3%, with margins improving to 31.5%. International patient revenue surged 48.5% to INR 762 million, and OPD pharmacy revenue rose 23.9% to INR 456 million, highlighting strong adoption of innovative healthcare solutions.
Medanta is evaluating strategic expansion to bring advanced tertiary care. By leveraging innovative technologies and strategic site selection, the company aims to improve healthcare accessibility, enhance diagnostic and treatment capabilities, and meet the growing regional demand for specialized medical services.
Other developments include capacity expansions in Patna and Lucknow and the upcoming 500–750 bed hospital in Mumbai, reflecting Medanta’s commitment to technological advancement and network-wide growth.
